ISTH Congress Abstracts

Official abstracts site for the ISTH Congress

MENU 
  • Home
  • Congress Archive
    • ISTH 2022 Congress
    • ISTH 2021 Congress
    • ISTH 2020 Congress
  • Resources
  • Search

A Comparative Study Of Intravenous Bolus Versus Bolus With Continuous Infusion Of Tranexamic Acid To Reduce Blood Loss In Major Surgical Procedures

N. NEERU1, V. ABRAHAM2

1Christian Medical College and Hospital, Ludhiana, Punjab, PATIALA, Punjab, India, 2Christian Medical College and Hospital, Ludhiana, Punjab, Ludhiana, Punjab, India

Abstract Number: VPB0636

Meeting: ISTH 2022 Congress

Theme: Fibrinolysis and Proteolysis » Fibrinolytic Factors and Inhibitors

Background: The major surgical procedures are associated with excessive blood loss and necessitate the need for blood transfusion in the absence of blood conservation strategies. Allogeneic blood transfusion carries significant risks of immunological reactions, transmission of disease, hemolysis, coagulopathy, renal failure, admission to ICU and even death. Tranexamic acid (TXA) is a synthetic antifibrinolytic drug that competitively blocks the lysine-binding sites of plasminogen, plasmin, and tissue plasminogen activator, thereby inhibiting fibrinolysis and blood clot degradation.

Aims: The aim of this study was to compare the efficacy of single intravenous bolus dose of tranexamic acid with bolus plus infusion dose of tranexamic acid in reducing intraoperative blood loss.

Methods: This study was conducted as prospective, randomized and controlled.120 patients of either sex, ASA grade I and II and aged between 18 to 65 years were included in the study. These patients were randomly divided into 3 groups i.e. Group A (bolus), Group B (bolus + infusion) and Group C(control).General anaesthesia was administered to the patient and the study drug was administered to the patient 10 minutes before the skin incision. Intraoperative blood loss and blood transfusions were noted.Data has been analysed using SPSS (Statistical Packages for Social Sciences, version 21.0. Armonk, NY: IBM corp.) .

Results: The intra-operative blood loss was least in the Bolus group and was maximum in the placebo group. The use of TXA significantly reduced the transfusion requirements in major surgeries with the least amount of transfusion needed in the Infusion group.

Conclusion(s): The use of TXA ( in bolus as well as the infusion) led to statistically significant reduction in blood loss and the requirement of transfusion. We would suggest the use of TXA in bolus dose pre-operatively before a radical surgical procedure to minimize the intra-operative blood loss and the requirement of transfusion.

TABLE

INTRA-OPERATIVE BLOOD LOSS

TABLE

INTRA-OPERATIVE TRANSFUSION

To cite this abstract in AMA style:

NEERU N, ABRAHAM V. A Comparative Study Of Intravenous Bolus Versus Bolus With Continuous Infusion Of Tranexamic Acid To Reduce Blood Loss In Major Surgical Procedures [abstract]. https://abstracts.isth.org/abstract/a-comparative-study-of-intravenous-bolus-versus-bolus-with-continuous-infusion-of-tranexamic-acid-to-reduce-blood-loss-in-major-surgical-procedures/. Accessed November 29, 2023.

« Back to ISTH 2022 Congress

ISTH Congress Abstracts - https://abstracts.isth.org/abstract/a-comparative-study-of-intravenous-bolus-versus-bolus-with-continuous-infusion-of-tranexamic-acid-to-reduce-blood-loss-in-major-surgical-procedures/

Simple Search

Supported By:

Takeda logo

ISTH 2022 Congress site

Visit the official web site for the ISTH 2022 Virtual Congress ยป

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2023 John Wiley & Sons, Inc. All Rights Reserved.
Wiley